Avanos Medical AVNS Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 50.5%-5.0pp | 55.4%-1.0pp | 56.4%-0.6pp | 57%+6.0pp | |
| Operating margin | -9.1%+48.5pp | -57.6%-58.2pp | 0.6%-6.0pp | 6.7%+13.3pp | |
| Net margin | -10.4%+46.6pp | -57%— | —— | 7%+5.9pp | |
| Returns | |||||
| Return on equity | -9.1%+28.9pp | -38%— | —— | 3.9%+3.4pp | |
| Return on invested capital | -7.5%+27.7pp | -35.2%-35.5pp | 0.3%-2.4pp | 2.7%+5.5pp | |
| Efficiency | |||||
| Asset turnover | 0.6×+0.1× | 0.5×+0.1× | 0.4×0.0× | 0.4×+0.1× | |
| Liquidity | |||||
| Current ratio | 2.2×-0.2× | 2.4×+0.3× | 2.1×-1.2× | 3.3×+0.2× | |
| Leverage | |||||
| Debt-to-equity | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×+0.1× | |
| Per Share | |||||
| Book value per share | $16.81-6.7% | $18.01-32.1% | $26.53-2.8% | $27.30+4.4% | |
| Valuation | |||||
| Market capitalization | $1.17B+108% | $731.64M-29.7% | $1.04B-17.2% | $1.26B-24.7% | |
| Price / sales | 1.6×+0.8× | 1.1×-0.5× | 1.5×-0.2× | 1.7×-1.1× | |
| Price / book | 1.5×+0.8× | 0.9×0.0× | 0.8×-0.1× | 1×-0.3× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Avanos Medical's profit margins?
- Avanos Medical (AVNS) runs a 50.0% gross margin and a -9.1% operating margin, with a -10.4% net margin.
- Where do Avanos Medical's ratios come from?
- Every ratio is computed from Avanos Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
